{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:38:23Z","timestamp":1788453503406,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bbrc.2020.03.100","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T08:23:17Z","timestamp":1585383797000},"page":"466-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor"],"prefix":"10.1016","volume":"526","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0555-3216","authenticated-orcid":false,"given":"Renate","family":"Louw-du Toit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet P.","family":"Hapgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donita","family":"Africander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.03.100_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2020.03.100_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2020.03.100_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/er.2017-00103","article-title":"Hormonal contraception and HIV-1 acquisition: biological mechanisms","volume":"39","author":"Hapgood","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2020.03.100_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"Africander","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.03.100_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A\u00a0comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"Africander","year":"2014","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","article-title":"Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy","volume":"491","author":"Louw-du Toit","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.03.100_bib8","first-page":"1","article-title":"The clinical impact of estrogen loss on cardiovascular disease in menopausal females","volume":"6","author":"Lopez-Pier","year":"2018","journal-title":"Med. Res. Arch."},{"key":"10.1016\/j.bbrc.2020.03.100_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00584","article-title":"Role of aldosterone and mineralocorticoid receptor in cardiovascular aging","volume":"10","author":"Gorini","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1204598","article-title":"Aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology","author":"Cannavo","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2020.03.100_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ehjcvp\/pvw016","article-title":"Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives","volume":"3","author":"Pitt","year":"2017","journal-title":"Eur. Heart. J. Cardiovasc. Pharmacotherapy"},{"key":"10.1016\/j.bbrc.2020.03.100_bib12","series-title":"Cell Biol. To Transl. Med. Brian","first-page":"1","article-title":"Transcriptional regulation and epigenetics in cardiovascular cells: role of the mineralocorticoid receptor","author":"Deng","year":"2019"},{"key":"10.1016\/j.bbrc.2020.03.100_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA\u00a0: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.03.100_bib14","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1073\/pnas.94.15.7879","article-title":"Steroid receptor induction of gene transcription: a two-step model","volume":"94","author":"Jenster","year":"1997","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.bbrc.2020.03.100_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2020.03.100_bib16","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(94)00003-F","article-title":"Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays","volume":"51","author":"Fuhrmann","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.bbrc.2020.03.100_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.bbrc.2020.03.100_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.bbrc.2020.03.100_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2020.03.100_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/09513599909167574","article-title":"The pharmacological profile of a novel norpregnane progestin (trimegestone)","volume":"13","author":"Philibert","year":"1999","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0039-128X(03)00142-9","article-title":"The preclinical biology of a new potent and selective progestin: trimegestone","volume":"68","author":"Winneker","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.bbrc.2020.03.100_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsbmb.2013.08.001","article-title":"Potency of progestogens used in hormonal therapy: toward understanding differential actions","volume":"142","author":"Hapgood","year":"2014","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2008.10.008","article-title":"Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction","volume":"299","author":"Ronacher","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-10-85","article-title":"Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative","volume":"10","author":"van Diepen","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.bbrc.2020.03.100_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.contraception.2010.11.017","article-title":"Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey","volume":"84","author":"Van Diepen","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bbrc.2020.03.100_bib27","first-page":"201","article-title":"Pharmacology of aldosterone and the effects of mineralocorticoid receptor blockade on cardiovascular systems","volume":"29","author":"Yagi","year":"2013","journal-title":"Acta Cardiol. Sin."},{"key":"10.1016\/j.bbrc.2020.03.100_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","article-title":"Inflammatory bio-markers and cardiovascular risk prediction","volume":"252","author":"Blake","year":"2002","journal-title":"J.\u00a0Intern. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2030591X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2030591X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:48:52Z","timestamp":1757764132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2030591X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0006291X2030591X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.100","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737669964.793573235","asserted-by":"object"}]},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}